---
figid: PMC5288206__oncotarget-07-53571-g006
figtitle: Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset
  of hepatocellular carcinomas
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5288206
filename: oncotarget-07-53571-g006.jpg
figlink: /pmc/articles/PMC5288206/figure/F6/
number: F6
caption: . Scheme of proposed SLC12A1 antagonist contributes to inhibition of liver
  cancer via the WNK1/ERK5 pathway.
papertitle: Treatment with an SLC12A1 antagonist inhibits tumorigenesis in a subset
  of hepatocellular carcinomas.
reftext: Fei Teng, et al. Oncotarget. 2016 Aug 16;7(33):53571-53582.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9585205
figid_alias: PMC5288206__F6
figtype: Figure
redirect_from: /figures/PMC5288206__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5288206__oncotarget-07-53571-g006.html
  '@type': Dataset
  description: . Scheme of proposed SLC12A1 antagonist contributes to inhibition of
    liver cancer via the WNK1/ERK5 pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLC12A1
  - WNK1
  - MAPK7
  - FOS
  - MYC
  - JUN
  - CCND1
  - Bumetanide
---
